India, May 31 -- AstraZeneca Pharma India has announced the appointment of Bhavana Agrawal as Chief Finance Officer (CFO) with effect from October 1, 2023, following a transition period. She succeeds Rajesh Marwaha, who is retiring as CFO and full-time director of the Company from the close of business hours on September 30, 2023.

Marwaha has been instrumental in building strategic frameworks for the company in India in tandem with the evolving environment of pharmaceutical sector in the country. As a board member, he has also been a strong anchor behind key initiatives focused on improving access to healthcare.

An All-India rank holder as a Chartered Accountant, Bhavana has been a strategic finance partner for businesses with consisten...